Complix to Present at Upcoming BioEquity Europe 2013: http://t.co/jzPUX0k7Bp
posted
FlandersBio offers an up-to-date life sciences database containing all the life sciences companies with biotech activity in Flanders, and all FlandersBio members. The guide provides easy and fast access to the local life sciences community.
Life Sciences Database filtered on Therapeutics
You can also perform a new search
Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious and life-threatening...
ActoGeniX is a biopharmaceutical company focused on the development and commercialization of ActoBiotics™, a novel class of orally available biopharmaceuticals for the targeted treatment of severe diseases with a high...
The objective of the company is to bring its first drug candidate to the clinic in 2 years. AlzProtect will develop its candidates up to clinical phase 2a before licensing them to a Pharma partner for further...
Amakem is a kinase platform company focusing on ophthalmology and is developing new treatments for serious eye conditions. The Company's lead candidate, AMA0076, targets glaucoma, a condition which damages the optic...
Amgen, a biotechnology pioneer, discovers, develops, and delivers innovative human therapeutics. Our medicines help millions of patients in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease,...
Apitope focuses on immunotherapies for the treatment of autoimmune and allergic diseases, including MS, factor VIII intolerance, uveitis and Graves’ disease. Apitope has a discovery platform which enables selection of...
Arcarios was fouded in 2010 as a merger of TR-therapeutics, a Belgian consortium headed by Tigenix NV and Therosteon BV. Arcarios is a drug development company dedicated to the discovery and development of innovative...
Arenco develops and commercializes antimalarials but also other (inlicensed) drugs in Africa. Arenco is a small independent pharmaceutical company that has developed a series of β-artemether based anti-malarials. The...
arGEN-X creates novel, antibody-based medicines using the SIMPLE Antibody™ platform to generate leads of unparalleled functional diversity, allowing optimal selection of mAb candidates. The proprietary NHance™ half-life...
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company.
We discover, develop, manufacture and market prescription medicines for six important areas of healthcare, which include some of the...
Beta-Cell is a privately owned biopharmaceutical company that develops novel cell therapy and other products related to Diabetes. The company is a spin-off from the Vrije Universiteit Brussel - Diabetes Research Center...
Biotech Tools develops new and original proprietary in vitro and in vivo biotech tools to improve diagnosis and improvement of immune response-related diseases. The tools include new proprietary heat shock protein-based...
Complix is a biopharmaceutical company engaged in the discovery and development of Alphabodies™, a revolutionary class of biopharmaceuticals with exceptional properties. Alphabodies™ combine beneficial properties of...
Dafra Pharma International is a total health care solution provider, bringing quality medicines within reach of patients in Africa for over 15 years. As the research branch of the Dafra group, Dafra Pharma R&D is...
Eurogentec is a leading provider of reliable and innovative products and services to the Life-Science, Diagnostic and Pharmaceutical community. Employing around 400 people worldwide and with a distribution network in...
Founded as a spin-off of the “Université Libre de Bruxelles”, Euroscreen initially develops and commercializes G Protein-Coupled Receptors (GPCR) reagents. Euroscreen is now developing a pipeline of preclinical...
Together on a mission to accelerate respiratory drug and device development worldwide.
FluidDA is the leading company in the research and development of imaging biomarkers to enhance drug development and patient care....
Formac Pharmaceuticals is a leading drug delivery company offering a unique mesoporous silica-based technology to enhance the oral bioavailability of poorly water-soluble active pharmaceutical ingredients (APIs).
In...
Galapagos is a mid-size biotechnology company specialized in the discovery and development of small molecule and antibody therapies with novel modes-of-action. The Company is progressing GLPG0634, as well as one of the...
Genzyme is a global biopharmaceutical company helping patients in more than 100 countries. Genzyme is Sanofi’s global center of excellence in rare diseases and multiple sclerosis (MS). In Geel, Belgium, Genzyme has a...
Based in Gosselies, Belgium, iTeos Therapeutics SA is a private biotechnology company with a focus on developing small-molecule immunomodulators for cancer treatment. Originating from a partnership between the Ludwig...
Janssen Infectious Diseases - Diagnostics is dedicated to advancing the treatment of contributing to positive change in HIV/AIDS, hepatitis C, tuberculosis, and other infectious diseases.
Janssen Pharmaceutica and other companies on our campus are part of the worldwide Janssen Pharmaceutical Group. Medicinal drugs for the benefit of patients, doctors and other health care professionals are discovered,...
MabCure is a biotechnology company whose vision is to change the perception of cancer as a largely incurable disease by early detection of cancer when the disease is still localized and treatable. The key to early...
Molmo Services is a molecular modeling and drug design company that provides a wide range of computational and research services for the chemical and pharmaceutical industry. It offers dedicated software for the most...
Today's Merck is a global healthcare leader, also known as MSD outside the US and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with...
Okapi Sciences aims at developing products to treat viral infections in animals, both pet animals and production animals. Viral infections remain a threat to food production and animal health. For several viral...
Omrix biopharmaceuticals aims to develop novel technologies to provide safer and more effective options to patients in areas with substantial unmet medical needs, particularly in the areas of biosurgical and passive...
Pharmaceutical company that develops and distibutes orphan drugs for the treatment of rare diseases
Oto Therapeutics identifies and develops novel medication for hearing disorders with primary focus on tinnitus.
Oxyrane develops improved therapeutic glycoproteins in the field of lysosomal storage disease products and antibodies using a glyco-engineered yeast production host and proprietary, purpose-built development tools.
Pfizer discovers, develops, manufactures and markets leading medicines for humans and animals. Their value-added products improve the quality of life of people around the world. Pfizer is a research based pharmaceutical...
The CNS Company PharmaNeuroBoost has two proprietary products in late clinical development stage: the antidepressant (AD) PNB01 in Phase III and the antipsychotic PNB02 in Phase IIa. The PNB01 phase III program is...
You have a promising drug molecule and you are preparing for Pre-clinical or Early Phase Clinical Studies? You are looking for contractors who can characterize, formulate, GMP produce, label and release your clinical...
Promethera® Biosciences is a biopharmaceutical company, spin-off of the Université Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology. Promethera® Biosciences'...
ReGenesys is a biopharmaceutical company focused on the research and development of stem cell based therapies. ReGenesys is a wholly-owned subsidiary of Athersys, a publicly held biotechnology company located in...
reMYND actively drives the development of disease modifying treatments against Alzheimer’s disease (AD), Parkinson’s disease (PD), and diabetes, either as a Contract Research Organisation (CRO) or through its own drug...
SEPS Pharma and SEPS Pharma Clinical Trial Manufacturing are privately held pharmaceutical companies engaged in drug delivery and development. The SEPS Pharma group provides advanced drug product development services...
Shire enables people with life-altering conditions to lead better lives. Through our deep understanding of patients’ needs, we develop and provide healthcare in the areas of:
Therabel invests in Phase 3 clinical trials of new molecules developed by reliable partners, and in the development of new galenic forms and indications of existing molecules. It has a single up-to-date production site...
ThromboGenics is dedicated to developing and commercializing new pharmacologic treatments that address important unmet clinical needs in ophthalmology and oncology.
By delivering on this goal ThromboGenics intends to...
TiGenix NV (NYSE Euronext Brussels: TIG) is a leading European cell therapy company with one product on the market for cartilage repair, and a strong pipeline with clinical stage allogeneic adult stem cell programs for...
Vanta Bioscience is a GLP accredited non-clinical outsourcing company that serves the pharma, biotech, chemicals, agrochemicals, feed, food, medical devices and cosmetics industries.
